Alzheimer's Disease Trial, Not Yet Recruiting NCT07741773 Sponsor: Augusta University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07741773
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who score 0.5 on a standard memory and thinking assessment called the Clinical Dementia Rating (CDR), or who score between 18 and 25 on another standard thinking and memory test called the Montreal Cognitive Assessment (MoCA).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had, or currently have, disease affecting the blood vessels that may also affect thinking and memory.
  • People who have had a stroke within the past year.
  • People who have had a mini-stroke (a brief episode where blood flow to the brain is temporarily blocked) within the past 180 days.
  • People who have a history of serious, significant injury to the brain or nervous system.
  • People who have a history of a tumour inside the skull.
  • People who have had, or currently have, kidney disease where a specific kidney function measurement falls below a certain level (confirm with trial site).
  • People who currently have a pacemaker fitted.
  • People who have metal in their body.
  • People who are allergic to an MRI dye called "Multihance," which is used during certain scans.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amal Kaddoumi, PhD, Augusta University

Phone: 7067234439

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Augusta University
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cerebrovascular function; Cerebrovascular blood flow; Cognitive function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov